Anne Putto-Laurila Selected Research

tocilizumab (atlizumab)

1/2020

Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Putto-Laurila Research Topics

Disease

3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2020 - 09/2011
2	Arthritis (Polyarthritis) 01/2018 - 01/2012
1	Fever (Fevers) 01/2014
1	Inflammation (Inflammations) 01/2012
1	Atrophy 01/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2002
1	Atherosclerosis 02/2002

Drug/Important Bio-Agent (IBA)

1	tocilizumab (atlizumab)FDA Link 01/2020
1	Prostaglandins AIBA 01/2018
1	AutoantibodiesIBA 01/2014
1	Antirheumatic Agents (DMARD)IBA 01/2012
1	pimecrolimus (Elidel)FDA Link 01/2010
1	Insulin (Novolin)FDA Link 01/2010
1	SodiumIBA 01/2010
1	Lipoproteins (Lipoprotein)IBA 02/2002

Therapy/Procedure

1	Therapeutics 01/2012
1	Drug Therapy (Chemotherapy) 09/2011
1	Combination Drug Therapy (Combination Chemotherapy) 09/2011